Evidence map›Paper›PMID 39055007›Full record

ArticleChemical science2024

Supramolecular engineering cascade regulates NIR-II J-aggregates to improve photodynamic therapy.

Huizhe Wang, Huijia Liu, Wenqing Li, Shuai Li, Jiaqi Zhang, Jingzhe Zang, Li Liu, Peng Wang

RetractedAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Huizhe WangDepartment of Biomedical Engineering, School of Engineering, China Pharmaceutical University Nanjing 210009 China wangpeng@cpu.edu.cn.
Huijia LiuDepartment of Biomedical Engineering, School of Engineering, China Pharmaceutical University Nanjing 210009 China wangpeng@cpu.edu.cn.
Wenqing LiDepartment of Biomedical Engineering, School of Engineering, China Pharmaceutical University Nanjing 210009 China wangpeng@cpu.edu.cn.
Shuai LiDepartment of Biomedical Engineering, School of Engineering, China Pharmaceutical University Nanjing 210009 China wangpeng@cpu.edu.cn.
Jiaqi ZhangDepartment of Biomedical Engineering, School of Engineering, China Pharmaceutical University Nanjing 210009 China wangpeng@cpu.edu.cn.
Jingzhe ZangDepartment of Biomedical Engineering, School of Engineering, China Pharmaceutical University Nanjing 210009 China wangpeng@cpu.edu.cn.
Li LiuDepartment of Biomedical Engineering, School of Engineering, China Pharmaceutical University Nanjing 210009 China wangpeng@cpu.edu.cn.
Peng WangDepartment of Biomedical Engineering, School of Engineering, China Pharmaceutical University Nanjing 210009 China wangpeng@cpu.edu.cn.ORCID https://orcid.org/0000-0003-2359-908X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rational design of small organic molecule-based NIR-II photosensitizers (PSs) with high singlet oxygen quantum yield in aqueous solution for deep tissue imaging and cancer therapy still presents challenges. Herein, we devised a general synthesis strategy to obtain six NIR-II region PSs with tunable aggregation states by adjusting the steric effect, and all PSs possess longer NIR absorption/emission wavelengths with tails extending beyond 1200 nm. Notably, ATX-6 possessed a singlet oxygen quantum yield of 38.2% and exhibited concentration-dependent J-aggregation properties upon self-assembly in an aqueous solution. What's more, supramolecular engineering with DSPE-PEG

Identifiers

PMID39055007
PMCPMC11268488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.